Wp Advisors, LLC Eli Lilly & CO Transaction History

Wp Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 23, 2019	SELL	$110.79 - $129.32 $32,793 - $38,278	-296 Closed	0 $0
Q1 2019 Apr 15, 2019	BUY	$111.31 - $131.02 $32,947 - $38,781	296 New	296 $384,000
Q4 2018 Jan 18, 2019	SELL	$105.9 - $118.64 $31,028 - $34,761	-293 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$85.86 - $107.31 $85 - $107	1 Added 0.34%	293 $31,000
Q2 2018 Jul 27, 2018	BUY	$75.7 - $86.88 $22,104 - $25,368	292 New	292 $25,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Wp Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wp Advisors, LLC with notifications on news.